Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Rudy Saucillo who wrote (1962)	3/1/1999 2:01:00 AM
From: rkrw	Read Replies (3) \| Respond to of 2742

Just a directive to the board. I don't hold shares personally and haven't for probably close to a year, so I'm an impartial observer. For all the sniveling and babying that gets posted to this board, criticism's of management, comparisons to IMNX stock, comparisons of market value to cash on hand, desires for a buyback, a reverse split and a listing and on and on. Everyone is in agreement that its ridiculous how a company can go on for such a prolonged period like this, selling for a fraction of cash value? DO SOMETHING ABOUT IT. Its been over 2 years since the settlement, enough is enough. The market cap is $5M give or take. A 5% stake would cost just $250,000 dollars. Surely amongst all the posters here, a 5% stake could be pooled together. If I were a shareholder I would try to force a liquidation, or an outright sale of the company.

To: Rudy Saucillo who wrote (1962)	3/1/1999 12:51:00 PM
From: Walter Morton	Respond to of 2742

Rudy, any comment on post 1954 (BSTC not interested in a CIST Merger)?

To: Rudy Saucillo who wrote (1962)	3/2/1999 7:04:00 PM
From: Walter Morton	Respond to of 2742

Next Fiscal Year Forecasted Results: Sales $5,000 Cost Of Sales 3,400 ------- 1,600 PMC Research $300,000 Lisence Fees 0 Royalties 35,000 -------- $336,600 R & D (500,000) Admin. (1,300,000) Occupancy (190,000) ---------- $(1,990,000) Oper Loss $(1,653,400) ============ Loss/Share $(.07) ====== ASSUMPTIONS: 24.3 million shares outstanding I left out any possible additional cash payments from IMNX because they don't have any affect on the stock price. I am assuming that Techne can increase sales of CIST's reagents by 20%, but is only paying a 5% royalty (very generous). I am also assuming that somebody will be let go -- marketing maybe.